Xu Liu

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 5

Top Topics

Dendritic Cells

Liver Metastases

Binding Protein

Top Venues

Journal of surgical oncology

Alimentary pharmacology & therapeutics

Bioscience reports

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Liu, Rong-Rong Jia, Chun-Yan Zhang
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma. Alimentary pharmacology & therapeutics 50 (3) (2020)
Jian-Xu Li, Xu Liu, Shao-Tong Tang, Guang-Lan Liang, Bang-De Xiang
Letter: are sorafenib-related adverse events associated with prolonged survival? Alimentary pharmacology & therapeutics 51 (1) (2020)
Wen-Feng Gong, Jian-Hong Zhong, Zhan Lu, Qiu-Ming Zhang, Zhi-Yuan Zhang, Chang-Zhi Chen, Xu Liu, Liang Ma, Zhi-Ming Zhang, Bang-De Xiang, Le-Qun Li
Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Bioscience reports 39 (8) (2019)
Dun-Chang Mo, Xu Liu, Yu-Jie Lv, Yan-Qiu Qin, Gui-Sheng Xie
Is monocyte-to-lymphocyte ratio the best systematic inflammatory biomarker for the prognosis of gastrointestinal stromal tumors? Journal of surgical oncology 119 (7) (2019)
Xian-Long Xie, Xu Liu, Jie Ou
Is synchronous hepatectomy and splenectomy superior to hepatectomy alone for selected patients with hepatocellular carcinoma and clinically significant portal hypertension? Journal of surgical oncology 120 (2) (2019)